stem cell leukemia

HLA-identical sibling allogeneic hematopoietic stem cell transplantation for chronic myelogenous leukemia in first chronic phase. Analysis of 51 cases

HLA相合同胞异基因造血干细胞移植治疗慢性粒细胞白血病第1次慢性期51例分析

Background: leukemia is a malignant desease from the hemopoietic stem cell ( HSC), it seriously threatens the health and lives of human beings.

背景白血病（leukemia）是造血干细胞克隆性增殖的肿瘤性疾病，严重威胁人类健康和生命。

The stem cell leukemia ( SCL ) gene is a new oncogene related with leukemogenesis.

干细胞白血病 ( CL ) 因是新发现的与白血病发生有关的癌基因.

Objective: To investigate the new method of HLA mismatched allogenic stem cell transplantation for leukemia.

目的探讨HLA不完全相合的造血干细胞移植治疗白血病的新方法。

The clinical study of HLA mismatched allogenic stem cell transplantation for leukemia

HLA位点不全相合的异基因干细胞移植治疗白血病的临床分析

Conclusion FLAG shows obvious efficts for refractory and relapsing acute leukemia and gains time for hematopoietic stem cell transplantation.

结论FLAG方案治疗难治复发AL疗效显著，为患者进行造血干细胞移植赢得了时机。

Objective To explore the chromosome karyotype and gene expression of leukemia after hematopoietic stem cell transplantation.

目的探讨造血干细胞移植后白血病细胞遗传学改变和基因表达的情况.